Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Selumetinib & Plexiform Neurofibromas (PN) / Neurofibroma

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Concerning Selumetinib & Plexiform Neurofibromas (PN) / Neurofibroma, Selumetinib is approved by both the FDA and in the European Union for plexiform neurofibromas, specifically in children with NF1 and symptomatic, inoperable tumors
Casey et al. 2021 Clin Cancer Res 27(15): 4142-4146

References (Sources)

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma
Casey et al. 2021 Clin Cancer Res 27(15): 4142-4146

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Selumetinib & Plexiform Neurofibromas (PN) / Neurofibroma

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat